“Research in Dermatology” is key to Stiefel’s focus on providing the highest quality, safe and effective dermatologicals to health care professionals and their patients.

When a patient presents with a skin problem, whether acne, rosacea, dry or photo-damaged skin, atopic dermatitis, psoriasis, warts, or other types of dermatoses, the first line of treatment will probably be a Stiefel product.

Innovative dermatological therapies from Stiefel, the leading company in Canada include:

• CLINDOXYL® Gel - The efficacy of clindamycin and benzoyl peroxide together in one tube. Clindoxyl is the most prescribed topical acne therapy in Canada;
• CLINDASOL® Cream - The first clindamycin cream for acne; Clindasol is ideal for patients with more sensitive skin;
• IMPRUV® Cream - An advanced moisturizer with Derma Membrane Structure for atopic skin conditions;
• STIEPROX® Shampoo - A unique shampoo offering prescription-strength antifungal activity for the treatment of dandruff and seborrheic dermatitis.

For more than 30 years, Stiefel Canada has provided Canadian Dermatologists with the latest therapies, excellent service and continuing support for educational and research projects.

Stiefel Canada President Richard J. MacKay was recently appointed Vice-Chairman of the Board of parent company Stiefel Laboratories, the world’s largest independent pharmaceutical company specializing in dermatologicals. He says, “We have high expectations of exciting results from our expanded international R & D program which will set the stage for a new generation of scientifically advanced skin care therapies.”

Stiefel is dedicated to advancing dermatology for the benefit of Dermatologists and their patients.

Click here to close this window
and return to the Dermatology Update Sponsors Page.